Cargando…
Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466995/ https://www.ncbi.nlm.nih.gov/pubmed/31024453 http://dx.doi.org/10.3389/fendo.2019.00215 |
_version_ | 1783411219108986880 |
---|---|
author | Langmia, Immaculate M. Kräker, Kristin Weiss, Sara E. Haase, Nadine Schütte, Till Herse, Florian Dechend, Ralf |
author_facet | Langmia, Immaculate M. Kräker, Kristin Weiss, Sara E. Haase, Nadine Schütte, Till Herse, Florian Dechend, Ralf |
author_sort | Langmia, Immaculate M. |
collection | PubMed |
description | Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero gene modification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included. |
format | Online Article Text |
id | pubmed-6466995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64669952019-04-25 Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR Langmia, Immaculate M. Kräker, Kristin Weiss, Sara E. Haase, Nadine Schütte, Till Herse, Florian Dechend, Ralf Front Endocrinol (Lausanne) Endocrinology Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero gene modification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included. Frontiers Media S.A. 2019-04-09 /pmc/articles/PMC6466995/ /pubmed/31024453 http://dx.doi.org/10.3389/fendo.2019.00215 Text en Copyright © 2019 Langmia, Kräker, Weiss, Haase, Schütte, Herse and Dechend. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Langmia, Immaculate M. Kräker, Kristin Weiss, Sara E. Haase, Nadine Schütte, Till Herse, Florian Dechend, Ralf Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title | Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title_full | Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title_fullStr | Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title_full_unstemmed | Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title_short | Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR |
title_sort | cardiovascular programming during and after diabetic pregnancy: role of placental dysfunction and iugr |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466995/ https://www.ncbi.nlm.nih.gov/pubmed/31024453 http://dx.doi.org/10.3389/fendo.2019.00215 |
work_keys_str_mv | AT langmiaimmaculatem cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT krakerkristin cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT weisssarae cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT haasenadine cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT schuttetill cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT herseflorian cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr AT dechendralf cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr |